Neelpatil780028 Sep, 2021Health
Growing adoption of high-content screening techniques in drug discovery and rising incidence of cancer primarily drives the market for live cell imaging. The growth in research funding and rising government funding and investment in regenerative medicine research will also support the market growth in the coming years. However, the high cost of high-content screening systems is limiting the overall adoption of these products.
Ee88
Cochran Cochrane
Owen Rye
Wang Nilsson
Wilkinson Munck
Puckett Cox
Hassan Boll
Tonnesen Moesgaard
Andersen Houghton
Rhodes Mcconnell